What are the causes of reduced fetal growth (intrauterine growth restriction)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Reduced Fetal Growth (Fetal Growth Restriction)

Suboptimal perfusion of the maternal-placental circulation is the most common cause of fetal growth restriction, accounting for 25-30% of all cases, followed by chromosomal disorders and congenital malformations which are responsible for approximately 20% of cases. 1

Primary Etiologic Categories

Placental Causes (Most Common)

  • Placental insufficiency due to suboptimal maternal-placental perfusion represents the leading cause, affecting 25-30% of FGR cases 1
  • This typically manifests as late-onset FGR (>32 weeks gestation) with asymmetric growth patterns occurring in 70-80% of growth-restricted infants 2
  • Placental dysfunction prevents adequate oxygen and nutrient delivery to the developing fetus 3

Fetal Causes

  • Chromosomal disorders and congenital malformations account for approximately 20% of FGR cases 1
  • Genetic imprinting disorders (such as Beckwith-Wiedemann syndrome and Silver-Russell syndrome) disrupt normal fetal growth mechanisms 4
  • These typically present as early symmetric growth restriction 2

Maternal Factors

Constitutional and Demographic:

  • Maternal age, weight, height, and race influence fetal growth potential 5
  • Primigravida status and small maternal size increase risk 2
  • Mother's own birth weight affects offspring growth 5

Nutritional Status:

  • Poor maternal nutrition is a key factor, particularly in socioeconomic contexts 3, 5
  • Maternal nutritional status before and during pregnancy directly affects nutrient availability to the fetus 3

Behavioral and Environmental:

  • Active and passive tobacco smoking represents one of the most significant modifiable risk factors 5
  • Alcohol and drug consumption during pregnancy 5
  • Maternal stress levels and occupational factors (total working hours, time spent standing, physical activity) 5

Medical Conditions:

  • Maternal hypertension and other vascular diseases 1
  • Chronic maternal diseases affecting placental function 6

Uterine and Mechanical Factors

  • Uterine malformations and uterine fibromata 2
  • Oligohydramnios and multifetal gestation 2
  • Early pelvic engagement of fetal head and aberrant fetal position 2
  • These extrinsic biomechanical constraints typically arise during late gestation 2

Clinical Context and Diagnostic Considerations

When evaluating FGR diagnosed at <32 weeks of gestation, chromosomal microarray analysis should be offered for unexplained isolated cases 1. However, screening for toxoplasmosis, rubella, or herpes is not recommended in the absence of other risk factors, though PCR for cytomegalovirus should be performed in women with unexplained FGR who elect diagnostic amniocentesis 1.

Important Caveats

The distinction between true FGR and constitutional smallness is critical—true FGR represents pathological growth restriction where the fetus fails to reach its genetic potential, whereas some small-for-gestational-age infants are constitutionally small but healthy 1, 6. This differentiation has significant implications for surveillance intensity and delivery timing, as FGR carries substantially higher risks of stillbirth (1.5% for <10th percentile, up to 2.5% for <5th percentile) compared to appropriately grown fetuses 1.

Environmental and behavioral modifications, particularly smoking cessation and optimization of maternal working conditions, represent the most effective preventive strategies for reducing FGR incidence 1, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Maternal predictors of intrauterine growth restriction.

Current opinion in clinical nutrition and metabolic care, 2013

Research

Intrauterine growth restriction--genetic causes and consequences.

Seminars in fetal & neonatal medicine, 2004

Research

Intrauterine growth retardation (IUGR): epidemiology and etiology.

Pediatric endocrinology reviews : PER, 2009

Research

Intrauterine growth restriction - part 1.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016

Related Questions

What are the management strategies and potential complications of intrauterine growth retardation (IUGR) in a high-risk pregnancy?
Which fetal abnormalities can cause intra‑uterine growth restriction (IUGR) and what are the recommended diagnostic and management approaches?
24‑year‑old primigravida at 35 weeks gestation (by LMP) with low‑normal fundal height, estimated fetal weight in the 10‑12th percentile (suspected intra‑uterine growth restriction/small for gestational age), history of polycystic ovarian syndrome, BMI 24.7 kg/m², bacterial vaginosis on pap smear, and asymptomatic bacteriuria with Pseudomonas fluorescens—what is the obstetric diagnosis and what diagnostic, therapeutic, birth, and postpartum management plans should be implemented, including three differential diagnoses with rationale?
What is the recommended nutrition and management plan to achieve catch‑up growth in an infant born with intrauterine growth restriction (IUGR)?
What is Intrauterine Growth Restriction (IUGR)?
What is the recommended duration and dosing schedule of oral vancomycin for an elderly patient with a third recurrence of Clostridioides difficile infection who cannot receive fidaxomicin?
What are the possible medical causes of a patient presenting with a cracked or ulcerated lateral tongue and simultaneous epistaxis?
What medication would you prescribe for an adult with non‑specific low back pain persisting for three months?
What is the target total testosterone level and recommended dosing regimen for testosterone supplementation in an adult male?
What are the causes of placental insufficiency?
What is the appropriate management of a pedunculated colonic polyp containing foci of adenocarcinoma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.